Fadie Thomas Coleman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia, Pneumococcal | 1 | 2017 | 130 | 0.540 |
Why?
|
| Streptococcus pneumoniae | 3 | 2022 | 721 | 0.540 |
Why?
|
| Macrophages, Alveolar | 1 | 2017 | 406 | 0.490 |
Why?
|
| Necrosis | 1 | 2017 | 1601 | 0.430 |
Why?
|
| NF-kappa B | 2 | 2017 | 2471 | 0.330 |
Why?
|
| Pseudomonas Infections | 5 | 2007 | 618 | 0.330 |
Why?
|
| Pneumonia, Bacterial | 4 | 2014 | 316 | 0.330 |
Why?
|
| Pseudomonas aeruginosa | 6 | 2007 | 1255 | 0.300 |
Why?
|
| Mouth | 1 | 2003 | 376 | 0.180 |
Why?
|
| Pharynx | 1 | 2003 | 429 | 0.180 |
Why?
|
| Natural Killer T-Cells | 1 | 2022 | 309 | 0.160 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 882 | 0.160 |
Why?
|
| Riboflavin | 1 | 2018 | 104 | 0.150 |
Why?
|
| Bacterial Vaccines | 3 | 2003 | 396 | 0.130 |
Why?
|
| Respiratory Mucosa | 1 | 2018 | 441 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2003 | 1261 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2085 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1439 | 0.080 |
Why?
|
| Immunity, Innate | 2 | 2017 | 3029 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 21717 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2014 | 1400 | 0.070 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2007 | 261 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 1894 | 0.060 |
Why?
|
| Alginates | 2 | 2004 | 247 | 0.060 |
Why?
|
| UTP-Glucose-1-Phosphate Uridylyltransferase | 1 | 2004 | 6 | 0.060 |
Why?
|
| Hexuronic Acids | 1 | 2004 | 145 | 0.060 |
Why?
|
| Glucuronic Acid | 1 | 2004 | 150 | 0.060 |
Why?
|
| Antibodies, Bacterial | 3 | 2004 | 1455 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2007 | 444 | 0.060 |
Why?
|
| Mice | 10 | 2022 | 80550 | 0.060 |
Why?
|
| Virulence | 2 | 2004 | 1294 | 0.050 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2002 | 86 | 0.050 |
Why?
|
| O Antigens | 1 | 2003 | 196 | 0.050 |
Why?
|
| Eye Infections, Bacterial | 1 | 2004 | 232 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 996 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10035 | 0.050 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2003 | 570 | 0.040 |
Why?
|
| Phagocytosis | 3 | 2018 | 1527 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2022 | 338 | 0.040 |
Why?
|
| Animals | 11 | 2022 | 166811 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 5785 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 17958 | 0.040 |
Why?
|
| Dendritic Cells | 2 | 2022 | 2715 | 0.040 |
Why?
|
| Lung | 6 | 2022 | 9898 | 0.040 |
Why?
|
| Cell Line | 3 | 2022 | 15634 | 0.040 |
Why?
|
| Pneumococcal Infections | 1 | 2022 | 498 | 0.040 |
Why?
|
| Cornea | 1 | 2004 | 1321 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2022 | 886 | 0.030 |
Why?
|
| Butyrate Response Factor 1 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 1765 | 0.030 |
Why?
|
| Inflammation | 1 | 2014 | 10696 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3122 | 0.030 |
Why?
|
| Mice, Inbred C3H | 2 | 2004 | 911 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 1757 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 748 | 0.030 |
Why?
|
| Rabbits | 3 | 2003 | 4761 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2018 | 1115 | 0.030 |
Why?
|
| Cytokines | 2 | 2018 | 7235 | 0.020 |
Why?
|
| Vaccines, Attenuated | 2 | 2003 | 312 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2022 | 5412 | 0.020 |
Why?
|
| Administration, Intranasal | 2 | 2003 | 472 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2014 | 815 | 0.020 |
Why?
|
| Vaccination | 1 | 2002 | 3322 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2003 | 9162 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 9101 | 0.020 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2007 | 41 | 0.020 |
Why?
|
| Diptera | 1 | 2007 | 53 | 0.020 |
Why?
|
| Female | 5 | 2022 | 386085 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2007 | 346 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2004 | 337 | 0.010 |
Why?
|
| Hybridomas | 1 | 2004 | 441 | 0.010 |
Why?
|
| Male | 2 | 2022 | 354908 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2004 | 417 | 0.010 |
Why?
|
| Blood Bactericidal Activity | 1 | 2003 | 126 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 2003 | 73 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2007 | 572 | 0.010 |
Why?
|
| 3-Phosphoshikimate 1-Carboxyvinyltransferase | 1 | 2002 | 6 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2007 | 579 | 0.010 |
Why?
|
| Vaccines, Conjugate | 1 | 2003 | 326 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 1977 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 2404 | 0.010 |
Why?
|
| Macrophages | 1 | 2014 | 5693 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2014 | 12739 | 0.010 |
Why?
|
| Vaccines, Synthetic | 1 | 2002 | 614 | 0.010 |
Why?
|
| Immunization | 1 | 2003 | 1218 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2007 | 2905 | 0.010 |
Why?
|
| Epitopes | 1 | 2003 | 2496 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3781 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 2214 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 6509 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2002 | 2665 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 7212 | 0.010 |
Why?
|
| Humans | 5 | 2022 | 752411 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 6112 | 0.010 |
Why?
|
| Pneumonia | 1 | 2004 | 2122 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14297 | 0.010 |
Why?
|
| Mutation | 2 | 2004 | 29706 | 0.000 |
Why?
|